SLAY EQ Trademark

Trademark Overview


On Thursday, May 23, 2024, a trademark application was filed for SLAY EQ with the United States Patent and Trademark Office. The USPTO has given the SLAY EQ trademark a serial number of 98565482. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, December 7, 2024. This trademark is owned by Medical Sales 101. The SLAY EQ trademark is filed in the Advertising, Business and Retail Services category with the following description:

Consulting in sales techniques and sales programmes; Consulting in the field of sales methods, sales management, and sales improvement; Information about sales methods
slay eq

General Information


Serial Number98565482
Word MarkSLAY EQ
Filing DateThursday, May 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, December 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesConsulting in sales techniques and sales programmes; Consulting in the field of sales methods, sales management, and sales improvement; Information about sales methods

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 23, 2024
Primary Code035
First Use Anywhere DateFriday, May 10, 2024
First Use In Commerce DateFriday, May 10, 2024

Trademark Owner History


Party NameMedical Sales 101
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFranklin, TN 37068

Trademark Events


Event DateEvent Description
Thursday, May 23, 2024NEW APPLICATION ENTERED
Sunday, December 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 7, 2024NON-FINAL ACTION E-MAILED
Saturday, December 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 7, 2024NON-FINAL ACTION WRITTEN
Saturday, December 7, 2024ASSIGNED TO EXAMINER